Supernus Pharmaceuticals reported $1.69B in Assets for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Aerie Pharmaceuticals AERI:US $ 385.34M 10.21M
Ani Pharmaceuticals ANIP:US $ 751.33M 6.49M
Aurora Cannabis Inc ACB:CN 1.08B 485.9M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Canopy Growth Corp WEED:CN C$ 3.52B 2.1B
Cara Therapeutics CARA:US $ 226.57M 2.71M
Corcept Therapeutics CORT:US $ 496.36M 28.24M
Eisai 4523:JP Y 1272871M 33556M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Endo International Ordinary Shares ENDP:US $ 6362.26M 2084.95M
Horizon Pharma HZNP:US $ 8853.47M 113.14M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Lannett LCI:US $ 484.44M 87.87M
Marinus Pharmaceuticals MRNS:US $ 109.38M 31.43M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Perrigo Ordinary Shares PRGO:US $ 10919.6M 530.1M
Revance Therapeutics RVNC:US $ 561.88M 77.66M
Supernus Pharmaceuticals SUPN:US $ 1694.97M 55.46M
Teva Pharmaceutical Industries TEVA:US $ 45932M 1127M
United Therapeutics UTHR:US $ 5543.3M 183.5M
Xeris Pharmaceuticals Inc XERS:US $ 318.62M 19.01M